Key Milestones Accomplished

​

​

• 2010-2015: 

  • ​NIH R01 Grant (NIH/ NIAMS) received to support proof-of-concept studies

• 2016: 

  • Technology Accelerator Award (Ohio Third Frontier) received for commercialization kick-start

• 2017-2018:

  • ​Pilot Translational Grant (NIH Roadmap CTSA/NTSA) received to support IND-enabling activities

• 2018: 

  • Amplicore Inc. Formed

• 2019:

  • Jan 7: First Pre-IND meeting with US FDA

  • ​Department of Defense award ($2M)  received to move AM3101 to clinical trial

  • 1st tranche of $3M closed for the Series Seed raised

​